Product Information

PAROXETINE CR 12.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4929 per EA under NDC 60505131603. Its NADAC has been published 320 times since May 13, 2020.

The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PAROXETINE CR 12.5 MG TABLET

paroxetine hydrochloride
$0.4929per EA
High Outlier

Strength

12.5 mg/1

Manufacturer

Apotex Corp.

NDC

60505131603

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PAROXETINE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020936

On Market Since

8/9/2019

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for PAROXETINE CR 12.5 MG TABLET has been published 320 times since May 13, 2020, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4929 per EA
All-time high$1.7329 (Jun 10, 2020)
All-time low$0.4365 (Jul 23, 2025)
52-week high$0.5254
52-week low$0.4365
Median price$0.8204
Average price$0.8169
Largest weekly change+48.4% (May 19, 2021)
Weeks tracked320
Tracking sinceMay 13, 2020

Price History

1W

0.0%

1M

-0.5%

3M

+0.0%

6M

+10.6%

1Y

+10.5%

3Y

-42.1%

5Y

-60.1%

All

-69.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PAROXETINE CR 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE CR 12.5 MG TABLET, manufactured by Apotex Corp., is $0.4929 per EA (NDC 60505131603), effective Jun 24, 2026.

How has the price of PAROXETINE CR 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PAROXETINE CR 12.5 MG TABLET has declined 69.7%. It has been tracked across 320 weekly CMS publications since May 13, 2020.

What are the highest and lowest recorded NADAC prices for PAROXETINE CR 12.5 MG TABLET?

Since May 13, 2020, the NADAC for PAROXETINE CR 12.5 MG TABLET has ranged from a low of $0.4365 (Jul 23, 2025) to a high of $1.7329 (Jun 10, 2020), with a median of $0.8204 per EA.

Are there cheaper alternatives to PAROXETINE CR 12.5 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as PAROXETINE CR 12.5 MG TABLET, but none are currently priced below it.

Who manufactures PAROXETINE CR 12.5 MG TABLET?

PAROXETINE CR 12.5 MG TABLET (NDC 60505131603) is labeled by Apotex Corp., and CMS classifies it as a generic product.